Code | CSB-PA858414ZA01HU |
Size | US$299 |
Image | |
The Latest Promotion | |
Have Questions? | Leave a Message or Start an on-line Chat |
The production of the KLHDC3 polyclonal antibody begins with the selection of a recombinant human KLHDC3 protein segment (amino acids 1-382) as the immunogen. This protein is employed to immunize a rabbit, resulting in an antibody response. The serum is then collected from the rabbit to extract polyclonal antibodies. These antibodies are subsequently purified via affinity chromatography, isolating them based on their specific reactivity to KLHDC3 protein. A thorough validation process confirms the antibody's specificity for human KLHDC3 protein in ELISA and WB assays.
KLHDC3 acts as an adaptor protein within the CRL2 complex, forming interactions with the C-terminal degron of p14ARF. This interaction leads to the proteasomal degradation of p14ARF in various cancer cell lines. Consequently, the CRL2-KLHDC3 E3 complex alleviates p14ARF-mediated inhibition of SLC7A11 transcription, thereby suppressing ferroptosis and promoting the pro-tumorigenic functions of KLHDC3.
There are currently no reviews for this product.